Literature DB >> 22226683

Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging.

H Quon1, D A Loblaw, P C F Cheung, L Holden, C Tang, G Pang, G Morton, A Mamedov, A Deabreu.   

Abstract

AIMS: To determine intra-fraction displacement of the prostate during extreme hypofractionated radiotherapy using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers.
MATERIALS AND METHODS: In total, 265 image pairs were obtained from 53 patients who underwent extreme hypofractionated radiotherapy to a dose of 35 Gy in five fractions on standard linear accelerators. Position verification was obtained with orthogonal X-rays before and after treatment and were used to determine intra-fraction prostate displacement.
RESULTS: The mean intra-fraction prostate displacements were -0.03 ± 0.61 mm (one standard deviation), 0.21 ± 1.50 mm and -0.86 ± 1.73 mm in the left-right, superior-inferior and anterior-posterior directions, respectively. The mean intra-fraction displacement during the first two fractions was moderately correlated with the displacement in the remaining three fractions, with correlation coefficients of 0.63 (95% confidence interval 0.43-0.77) and 0.47 (95% confidence interval 0.22-0.65) in the superior-inferior and anterior-posterior directions, respectively. There was no significant correlation in the left-right direction with a coefficient of -0.04 (95% confidence interval -0.31-0.23).
CONCLUSIONS: The mean intra-fraction prostate displacement during a course of extreme hypofractionated radiotherapy is small. A strategy using the first two fractions to predict future displacements >5 mm warrants further validation.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226683     DOI: 10.1016/j.clon.2011.12.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  9 in total

Review 1.  Fiducial marker guided prostate radiotherapy: a review.

Authors:  Angela G M O'Neill; Suneil Jain; Alan R Hounsell; Joe M O'Sullivan
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

2.  The non-Gaussian nature of prostate motion based on real-time intrafraction tracking.

Authors:  Yuting Lin; Tian Liu; Wells Yang; Xiaofeng Yang; Mohammad K Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-09       Impact factor: 7.038

3.  Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR).

Authors:  Alexandru Nicolae; Melanie Davidson; Harry Easton; Joelle Helou; Hima Musunuru; Andrew Loblaw; Ananth Ravi
Journal:  Radiat Oncol       Date:  2015-05-30       Impact factor: 3.481

4.  Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT).

Authors:  Louise J Murray; Vivian Cosgrove; John Lilley; Jonathan Sykes; Christopher M Thompson; Kevin Franks; David Sebag-Montefiore; Ann M Henry
Journal:  Radiother Oncol       Date:  2013-12-11       Impact factor: 6.280

Review 5.  Evolution of hypofractionated accelerated radiotherapy for prostate cancer - the sunnybrook experience.

Authors:  Hima Bindu Musunuru; Patrick Cheung; Andrew Loblaw
Journal:  Front Oncol       Date:  2014-11-14       Impact factor: 6.244

6.  Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT).

Authors:  Adam Gladwish; Geordi Pang; Patrick Cheung; Laura D'Alimonte; Andrea Deabreu; Andrew Loblaw
Journal:  Radiat Oncol       Date:  2014-11-28       Impact factor: 3.481

7.  The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams.

Authors:  Hunor Benedek; Minna Lerner; Per Nilsson; Tommy Knöös; Adalsteinn Gunnlaugsson; Crister Ceberg
Journal:  Phys Imaging Radiat Oncol       Date:  2018-05-25

8.  Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy.

Authors:  Denis Panizza; Valeria Faccenda; Raffaella Lucchini; Martina Camilla Daniotti; Sara Trivellato; Paolo Caricato; Valerio Pisoni; Elena De Ponti; Stefano Arcangeli
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

9.  A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.

Authors:  Ciara A Lyons; Raymond B King; Sarah O S Osman; Stephen J McMahon; Joe M O'Sullivan; Alan R Hounsell; Suneil Jain; Conor K McGarry
Journal:  Radiat Oncol       Date:  2017-08-04       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.